• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,4-苯二氮䓬开环衍生物450191-S的生物制药特性。II. 大鼠肝脏首过提取减少的证据。

Biopharmaceutical characterization of 450191-S, a ring-opened derivative of 1,4-benzodiazepine. II. Evidence for reduced first-pass extraction by rat liver.

作者信息

Koike M, Futaguchi S, Takahashi S, Sugeno K

机构信息

Shionogi Research Laboratories, Shionogi and Co., Ltd., Osaka, Japan.

出版信息

Drug Metab Dispos. 1988 Jul-Aug;16(4):609-15.

PMID:2903031
Abstract

The new hypnotic, 5-[(2-aminoacetamido)methyl]-1-[p-chloro-2-(o- chlorobenzoyl)phenyl]-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide hydrochloride dihydrate (450191-S), is a ring-opened derivative of 1,4-benzodiazepine that is activated by spontaneous cyclization via a labile desglycylated metabolite (191DG). Pharmacokinetic comparison between 450191-S and its primary active metabolite, 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazole[1,5-a][1,4] benzodiazepine-2-carboxamide (M-1), in rats revealed that higher levels of active metabolites were produced after 450191-S administration. To find the causes for this, in vivo and in vitro experiments were performed with the focus on hepatic uptake. Study of the absorption and distribution of radioactivity after intraduodenal administration of [14C]450191-S and [14C]M-1 revealed that most of the radioactivity was in the liver, with absorption of M-1 being rapid regardless of the dose and the absorption of 450191-S being slower at higher doses. Comparison of the portal and systemic metabolite levels showed the hepatic first-pass extraction after M-1 administration to be more effective than that after 450191-S administration. This was attributed to the labile intermediate, 191DG, which reduced the first-pass extraction in the liver. This reduction was confirmed by pharmacokinetic analysis after portal injection of 191DG in vivo and by incubation with liver slices in vitro. Thus, the presence of 191DG improved the bioavailability of active metabolites after 450191-S administration.

摘要

新型催眠药5-[(2-氨基乙酰氨基)甲基]-1-[对氯-2-(邻氯苯甲酰基)苯基]-N,N-二甲基-1H-1,2,4-三唑-3-甲酰胺盐酸盐二水合物(450191-S)是1,4-苯二氮䓬的开环衍生物,通过不稳定的去甘氨酰化代谢物(191DG)自发环化而被激活。450191-S与其主要活性代谢物8-氯-6-(2-氯苯基)-N,N-二甲基-4H-1,2,4-三唑并[1,5-a][1,4]苯二氮䓬-2-甲酰胺(M-1)在大鼠体内的药代动力学比较显示,给予450191-S后产生的活性代谢物水平更高。为找出原因,以肝脏摄取为重点进行了体内和体外实验。十二指肠内给予[14C]450191-S和[14C]M-1后放射性吸收和分布的研究表明,大部分放射性存在于肝脏中,M-1的吸收迅速,与剂量无关,而450191-S在高剂量时吸收较慢。门静脉和全身代谢物水平的比较显示,给予M-1后肝脏首过提取比给予450191-S后更有效。这归因于不稳定的中间体191DG,它降低了肝脏中的首过提取。体内门静脉注射191DG后的药代动力学分析以及体外与肝切片孵育证实了这种降低。因此,191DG的存在提高了给予450191-S后活性代谢物的生物利用度。

相似文献

1
Biopharmaceutical characterization of 450191-S, a ring-opened derivative of 1,4-benzodiazepine. II. Evidence for reduced first-pass extraction by rat liver.1,4-苯二氮䓬开环衍生物450191-S的生物制药特性。II. 大鼠肝脏首过提取减少的证据。
Drug Metab Dispos. 1988 Jul-Aug;16(4):609-15.
2
N-hydroxymethyl metabolites of 450191-S, a 1H-1,2,4,-triazolyl benzophenone derivative, in dog plasma.1H-1,2,4-三唑基二苯甲酮衍生物450191-S在犬血浆中的N-羟甲基代谢产物。
Drug Metab Dispos. 1987 May-Jun;15(3):426-8.
3
Biopharmaceutical characterization of 450191-S, a ring-opened derivative of 1,4-benzodiazepine. I. Active metabolite levels in rat plasma.1,4-苯二氮䓬开环衍生物450191-S的生物制药特性。I. 大鼠血浆中的活性代谢物水平。
J Pharmacobiodyn. 1986 Jul;9(7):563-9. doi: 10.1248/bpb1978.9.563.
4
Intestinal activation of a new sleep inducer 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, in rats.新型睡眠诱导剂450191-S(一种1H-1,2,4-三唑基二苯甲酮衍生物)在大鼠肠道中的激活作用。
J Pharmacobiodyn. 1986 Mar;9(3):315-20. doi: 10.1248/bpb1978.9.315.
5
Structure determination of metabolites of rilmazafone, a 1H-1,2,4-triazolyl benzophenone derivative in monkey urine.1H-1,2,4-三唑基二苯甲酮衍生物瑞马唑仑在猴尿中代谢产物的结构鉴定
Xenobiotica. 1988 Mar;18(3):257-68. doi: 10.3109/00498258809041662.
6
NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.国家毒理学计划关于水合氯醛(化学物质登记号:302-17-0)毒性和代谢研究的技术报告。通过灌胃法给予F344/N大鼠和B6C3F1小鼠。
Toxic Rep Ser. 1999 Aug(59):1-66, A1-E7.
7
Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.N,N-二乙基间甲苯酰胺在大鼠体内的吸收、分布、代谢及排泄
Drug Metab Dispos. 1996 Feb;24(2):156-63.
8
Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.开发一种体内临床前筛选模型以评估外源性物质的吸收和首过肝提取率。II. 使用酮康唑鉴定猴体内P-糖蛋白/CYP3A限制的生物利用度。
Drug Metab Dispos. 2004 Feb;32(2):172-7. doi: 10.1124/dmd.32.2.172.
9
Uptake of 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, in the everted sac of rat small intestine: role of intestinal aminopeptidases.1H-1,2,4-三唑基二苯甲酮衍生物450191-S在大鼠小肠外翻囊中摄取:肠道氨肽酶的作用
J Pharmacobiodyn. 1986 Jun;9(6):513-6. doi: 10.1248/bpb1978.9.513.
10
Induction of rat liver microsomal drug-metabolizing enzymes by a new sleep inducer 450191-S and plasma levels of 450191-S-metabolites.新型睡眠诱导剂450191-S对大鼠肝脏微粒体药物代谢酶的诱导作用及450191-S代谢产物的血浆水平
J Pharmacobiodyn. 1986 Mar;9(3):249-56. doi: 10.1248/bpb1978.9.249.